Attenuation of Anxiety-Like Behavior by Helichrysum stoechas (L.) Moench Methanolic Extract through Up-Regulation of ERK Signaling Pathways in Noradrenergic Neurons

Abstract

The long-term use of anxiolytic and antidepressant drugs can cause a plethora of side effects and the use of complementary and alternative medicine, which is generally considered safer than conventional medicine, is consistently increasing. Helichrysum stoechas (L.) Moench methanolic extract (HSE) has shown MAO-A inhibitory properties in previous studies. With the aim of obtaining innovative and safer therapies for mood disorders, this study investigated the potential activity of HSE in the management of anxiety- and depression-related symptoms. HSE showed dose-dependent (30–100 mg/kg p.o.) anxiolytic-like activity in the light dark box and marble burying tests, without any antidepressant-like activity, as shown by the results of the tail suspension test. Additionally, HSE did not have any effect on the modulation of pain, which highlights its selectivity in the control of anxiety-related behavior. At active doses, HSE did not produce any sedative effect or result in impaired motor coordination and memory functions. Western blotting experiments showed the ability of HSE to counteract the reduction in the phosphorylation of ERK44/42, to restore brain-derived neurotrophic factor (BDNF) expression and to return cyclic AMP response element binding (CREB) levels to basal levels in noradrenergic hippocampal neurons of mice exposed to an anxiety-related environment, which indicates a protective role against anxiety behavior. These results suggest that oral administration of HSE might represent an interesting opportunity for the management of anxiety disorders.

The Potential Role of Everlasting Flower (Helichrysum stoechas Moench) as an Antihypertensive Agent: Vasorelaxant Effects in the Rat Aorta

“…Until now, in vitro studies have shown that this plant has strong antioxidant and anti-inflammatory activities and antimicrobial capacity as well as antiproliferative and antidiabetic effects [ 12 ]. Recently, neuroprotective effects were observed in in vitro and in vivo studies [ 12 , 27 ]. However, the vascular activity of H. stoechas is unknown.…”

Rosmarinic Acid Reduces Microglia Senescence: A Novel Therapeutic Approach for the Management of Neuropathic Pain Symptoms

“…This rod is placed at a height of about 15 cm from the base of the instrument. The speed of the rod was 16 rpm and the time in which the number of falls of the animal was calculated was 30 s. This test was performed in the baseline (BL) condition and at day 21–28 after surgery [ 23 ].…”

“…The longer the animal remained in the center of the box, the less anxious it was. This test was performed in the baseline condition (BL) and on day 21–28 after surgery [ 23 ].…”

“…The time spent in the light compartment and the number of transitions was used as a sign of the anxiety state of each animal. This test was performed on day 21–28 after surgery [ 23 ].…”

Neuroimmune crosstalk through brain-derived neurotrophic factor and its precursor pro-BDNF: New insights into mood disorders

“…In Europe, for example, the current burden is greater than that from 10 years ago despite the availability of reasonably effective pharmacological and psychological interventions[ 3 ]. Moreover, the World Health Organization in 2008 ranked major depression as the third cause of the disease burden worldwide and predicted that the disease will rank first by 2030[ 4 ]. Furthermore, various studies have shown the impact of depression, anxiety and stress on different systems including the cardiovascular and immune systems[ 5 ].…”